Brain Shunt Recall: Gravity Compensating Accessory
The FDA posted a notice yesterday about a Class 1 recall issued by Integra NeuroSciences for their Gravity Compensating Accessory (High Pressure Range), part of a brain shunt system used to prevent too much fluid from being redirected from the brain to the abdomen while sitting or standing.
The device is being recalled because it may leak cerebrospinal fluid, which could cause inflammation of the spinal cord, brain or abdominal membranes, failure of the shunt system or exert pressure on the wound created by implantation of the device.
The product is marketed as the “Gravity Compensating Accessory (GCA), High Pressure Range, Sterile, Single Use, Prescription Use (Rx) only”. The recalled devices were distributed between February 22, 2008 through June 1, 2008.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
A brain shunt is a hole or passage which redirects fluid from the brain to the abdomen, and the Gravity Compensating Accessory (GCA) is designed to counterbalance the effect of gravity within the shunt system. It prevents the sudden loss of too much cerebrospinal fluid from the central nervous system when an individual stands or sits.
The Gravity Compensating Accessory comes in three ranges of pressure or flow resistance, low, medium and high. It consists of stainless steel balls that change flow resistance through a ball and cone mechanism.
The FDA posted notice of the brain shunt device recall on their MedWatch page on December 11, 2008, notifying hospital surgical and neurological healthcare professions about the problems with the product.
The recall was first initiated by Integra NeuroSciences on October 3, 2008 and the company has sent letters directly to hospitals and other customers to directly notify doctors who may have implanted the device.
The brain shunt accessory recall was classified as a Class 1 recall, which indicates that use of the product poses a reasonable probability of serious injury or death.
"*" indicates required fields
More Top Stories
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.